Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-008547)
National Institutes of Health (P30‐CA14051, 2T32GM008334)
Received: 18 November 2020
Accepted: 21 April 2021
First Online: 1 May 2021
: Animal studies were reviewed and approved by The Institutional Committee for the Care and Use of Experimental Animals at INTA CICVyA, Argentina, evaluation request number 55/2018, “Immunogenic quality control of subunit vaccines for human rotavirus in guinea pigs.”
: Not applicable.
: L.E.C., K.R.L., and J.C.L. have filed patents related to the InSCyT system and methods. K.R.L. and J.C.L. are co-founders and consultants to Sunflower Therapeutics PBC.